Cynthia M. Nijenhuis
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Phenotypic and Functional Characteristics of CD8+ T Cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 27, 2025
Phenotypic and Functional Characteristics of CD8+ T cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 27, 2025
NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy.
Journal: Nature communications
Published: June 05, 2025
Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial.
Journal: The British journal of surgery
Published: December 24, 2024
Health-related quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared with ipilimumab in a randomized phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 11, 2024
Defining the Quality Attributes for Tumor-Infiltrating Lymphocyte Medicinal Products.
Journal: Transplantation and cellular therapy
Published: March 26, 2024
Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial.
Journal: Journal for immunotherapy of cancer
Published: February 26, 2024
Basics of advanced therapy medicinal product development in academic pharma and the role of a GMP simulation unit.
Journal: Immuno-oncology technology
Published: January 09, 2024
Exposure-response analyses of BRAF- and MEK-inhibitors dabrafenib plus trametinib in melanoma patients.
Journal: Cancer chemotherapy and pharmacology
Published: December 28, 2022
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
Journal: The New England journal of medicine
Published: December 08, 2022
Last Updated: 09/26/2026